Peptide Research, Metabolic Biology and Clinical Evidence

Health Theorem helps ordinary readers make sense of peptide research, metabolic biology, and fast-moving clinical claims. Coverage starts with the question behind the headline: what was actually studied, in whom, for how long, and against what comparison? Specialized terms are explained in plain English, with a clear distinction between a plausible biological mechanism and evidence that can support conclusions about human health.

The publication covers natural peptide signaling, approved prescription medicines, investigational candidates, compounded products, supplements and cosmetics, and research-use-only materials without treating them as interchangeable. It examines GLP-1, GIP, glucagon, appetite regulation, body composition, collagen and skin research, safety questions, and trial interpretation, with attention to evidence level, study population, endpoints, duration, effect size, and meaningful uncertainty.

Explore the evidence

A clearer way to read health research

A study can be interesting without settling a health question. Cell and animal findings may clarify mechanisms but cannot establish clinical benefit. Early trials may show tolerability or preliminary signals while leaving effectiveness uncertain. Even randomized trials need context: the comparator, participant characteristics, outcome measured, follow-up period, and absolute size of a result can change what a headline means. Health Theorem brings those distinctions forward and explains what remains unknown. The goal is informed interpretation rather than personalized treatment selection: enough biology to understand the claim, enough study context to judge its strength, and clear boundaries around conclusions the evidence cannot support.